
Penn-BioNTech Innovative Therapeutics Seed Fund Unveils Its First Investment to Advance Therapeutic Innovation
Penn-BioNTech Innovative Therapeutics Seed Fund Reveals Its First Investment to Advance Therapeutic Innovation The Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund) has announced its investment in Emvena Therapeutics, a biotechnology company developing innovative messenger RNA (mRNA) medicines designed to deliver…














